Weight loss improves disease activity in patients with psoriatic arthritis and obesity: An interventional study
Availability note: Medication availability and Health Canada approvals can change over time
Semaglutide is the active ingredient in blockbuster obesity treatments, including Wegovy and Ozempic
Tirzepatide produces greater average weight loss than semaglutide in clinical trials, roughly 22.5% versus 15% at maximum doses
As the biosynthesis process depends on the addition of nitrogen sources, such as glycine and hypoxanthine, selection for strains resistant to the adenine antimetabolite, 4-aminopyrazolo (3, 4-d) pyrimidine, improved production (Park et al., 2007, 2011
She has developed a large audience via her successful podcast and digital media